15 June 2020 - Despite the efforts of the European Union to promote voluntary cooperation among Health Technology Assessment agencies, different reimbursement decisions for the same drug are made across European countries. 

The aim of this paper is to compare the agreement of cancer drug reimbursement decisions using inter-rater reliability measures.

Read International Journal of Technology Assessment in Health Care article